Table 1.
Characteristics of Each Treatment Group
| Variable | TDB-L | TD-L | p-value | |
|---|---|---|---|---|
| No. of eyes | 23 | 24 | ||
| Sex, M / F | 33.3% / 66.7% | 35.7% / 64.3% | 0.899a | |
| Age, years | 63.0 ± 12.2 | 70.9 ± 7.9 | 0.058b | |
| BMI, Kg/m2 | 26.9 ± 4.23 | 27.4 ± 3.84 | 0.748b | |
| BMI Categories | Healthful weight | 41.7% | 35.7% | 0.883a |
| Overweight | 33.3% | 42.9% | ||
| Obesity | 25% | 21% | ||
| Use of concomitant medications | 66% | 92.9% | 0.199a | |
Notes: For continuous variables, data are presented as mean ± standard deviation. groups. achi-square test and bt-test are used. All p-values between groups are> 0.05.
Abbreviations: BMI, body mass index; F, female; M, male; TDB-L, fixed combination of timolol, dorzolamide, and brimonidine with latanoprost; TD-L, fixed combination of timolol, dorzolamide with latanoprost.